Zymeworks Inc. expected to post a loss of 46 cents a share - Earnings Preview

Zymeworks

04/08/2026 21:44

Zymeworks Inc. ZYME.OQ ZYME.O is expected to  show a fall in quarterly revenue when it reports  results on August 6 for the period ending June 30 2026
The Middletown Delaware-based  company is expected to report a 63.0% decrease in revenue to $18.011 million from $48.73 million a year ago, according to the mean estimate from 10 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Zymeworks Inc. is for a loss of 46 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Zymeworks Inc. is $37.00, about 69.6% above its last closing price of $21.81
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.28
-0.19
-0.59
Missed
-207.3
Dec. 31 2026
-0.44
-0.42
-0.55
Missed
-32.1
Sep. 30 2025
-0.29
-0.32
-0.26
Beat
19​
Jun. 30 2025
-0.48
-0.49
0.03
Beat
106.1
​​Mar. 31 2025
-0.40
-0.41
-0.30
Beat
26.6
Dec. 31 2024
-0.17
-0.10
-0.31
Missed
-213.1​
Sep. 30 2024
-0.31
-0.40
-0.39
Beat
1.4
Jun. 30 2024
-0.33
-0.32
-0.27
Beat
14.7
This summary was machine generated August 4 at 20:44 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)